product summary
Loading...
company name :
Alomone Labs
product type :
chemical
product name :
N-Formyl-Met-Leu-Phe
catalog :
GPF-100
more info or order :
image
image 1 :

Alomone Labs N-Formyl-Met-Leu-Phe activates Ca2+transients in differentiated HL-60 cells. - Cells were loaded with Fluo-3 AM. Changes in intracellular Ca2+were detected via changes in Fluo-3 emission following application (indicated by arrow) of 1 MN-Formyl-Met-Leu-Phe(#GPF-100) (green) compared to control (black saline perfusion).
image 2 :

Cell surface detection of Semaphorin-4D in live intact human Jurkat T-cell leukemia cells: - ___Cells.___Cells + goat-anti-rabbit-FITC.___Cells +Anti-Semaphorin-4D (SEMA4D) (extracellular) Antibody (#ASR-064) (2.5 g) + goat-anti-rabbit-FITC.
product information
cat :
GPF-100
SKU :
GPF-100_10 mg
Product Name :
N-Formyl-Met-Leu-Phe
Group Type :
Non Antibodies
Product Type :
Proteins
Applications :
Calcium imaging assay
Formulation :
Lyophilized Powder.
Storage After Reconstitution :
Store the reconstituted solution for the shortest time possible at -20°C. We do not recommend storing the product in working solution for longer than one day. Avoid multiple freeze-thaw cycles.
Reconstitution and Solubility :
Centrifuge the vial (10,000 × g for 5 minutes) before adding solvent to spin down all the powder to the bottom of the vial. The lyophilized product may be difficult to visualize. Add solvent directly to the centrifuged vial. Gently tap, tilt, and roll the vial to aid dissolution. Avoid vigorous vortexing; light vortexing for up to 3 seconds is acceptable if needed. Soluble in DMSO. Prepare a concentrated stock solution by dissolving the lyophilized peptide in DMSO first (e.g., at a concentration between 100-1000x of the final working concentration). Once the peptide is completely dissolved in DMSO, slowly dilute the solution into the working buffer (or water) to the desired final working concentration. Centrifuge all product preparations before use. Avoid multiple freeze-thaw cycles to maintain biological activity. It is recommended to keep the DMSO concentration as low as possible. For cell assays, a final concentration of 0.1%–0.5% DMSO (v/v) is considered safe. For other experiments, a 5% DMSO (v/v) concentration is recommended.
Solubility :
Centrifuge the vial before adding solvent (10,000 x g for 5 minutes). The lyophilizate may be difficult to visualize. Add solvent directly to the centrifuged vial. Tap the vial to aid in dissolving the lyophilized product. Tilt and gently roll the liquid over the walls of the vial. Avoid vigorous vortexing. Light vortexing for up to 3 seconds is acceptable if needed. Soluble in DMSO. Prepare a concentrated stock solution by dissolving the lyophilized peptide in DMSO first (e.g., at a concentration between 100-1000x of the final working concentration). Once the peptide is completely dissolved in DMSO, slowly dilute the solution into the working buffer (or water) to the desired final working concentration. Centrifuge all product preparations before use. It is recommended to keep the DMSO concentration as low as possible. For cell assays, a final concentration of 0.1%–0.5% DMSO (v/v) is considered safe. For other experiments, a 5% DMSO (v/v) concentration is recommended.
Storage Before Reconstitution :
The product is shipped as a lyophilized powder at room temperature. Upon receipt, store the product at -20°C. Protect from moisture.
Source :
Synthetic peptide
Gene ID :
FPR1
Product Page - Scientific background :
Chemotactic factors from both Gram-positive and Gram-negative bacteria are short peptides with N-formyl methionine at the N-terminus (extensively reviewed in reference 1). These peptides are released from bacteria during infection and activate formyl peptide receptors (FPR), members of the G-protein coupled receptor (GPCR) superfamily. In humans, the FPR family consists mainly of three receptors, FPR1, FPR2/ALX (formerly FPRL1), and FPR3 (formerly FPRL2) which all couple to the Gi subtype of G-proteins and ultimately lead to the activation of phospholipase C and intracellular Ca2+ increase1,2.N-Formyl-Met-Leu-Phe is a selective and potent agonist of the Formyl peptide receptor (FPR1)3.In human polymorphonuclear leukocytes N-formyl-met-leu-phe activates p38 by a process involving phosphatidylinositol 3-kinase, protein kinase C, and calcium4. N-Formyl-Met-Leu-Phe increased in a dose-dependent manner (0.1 nM - 1 µM) the adherence of neutrophils to vascular endothelial cells which is the initial event in the migration of neutrophils through blood vessel walls to tissue sites of inflammation5.
Supplier :
Alomone Labs
Target :
FPR1 receptor
Long Description :
A Potent Agonist of FPR1 G-Protein Coupled Receptor
Short Description :
A Potent Agonist of FPR1 G-Protein Coupled Receptor
MW :
437.6 Da
Synonyms :
FMLP, N-formyl-L-methionyl-L-leucyl-L-phenylalanine, N-formyl-MLF
Modifications :
Met1 - N-formyl-Met.
Molecular formula :
C21H31N3O5S
Effective Concentration :
1 nM - 10 μM
Activity :
N-Formyl-Met-Leu-Phe is a selective and potent agonist of the formyl peptide receptor (FPR1)1.
Storage of solutions :
Store the reconstituted solution at -20°C for the shortest time possible. Avoid multiple freeze-thaw cycles. We do not recommend storing the product in working solutions for longer than a day.
Lead Time :
1-2 Business Days
Country of origin :
Israel/IL
Purity :
≥98% (HPLC)
CAS No :
59880-97-6
Form :
Lyophilized
Comment :
Contact Alomone Labs for technical support and product customization
Sequence :
MLF-OH
Is Toxin :
No
UNSPSC :
12352202
Bioassay Tested :
yes
Steril endotoxin free :
no
more info or order :
company information

Alomone Labs
Jerusalem BioPark (JBP), Hadassah Ein Kerem
P.O. Box 4287
Jerusalem 9104201
P.O. Box 4287
Jerusalem 9104201
info@alomone.com
http://www.alomone.com972 2 531 8002
headquarters: Israel
related products
browse more products
questions and comments